Concepedia

Dennis Feng

DF

Statistics

Publications

19

Citations

799

H-Index

16

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Scynexis (United States)

Dennis Feng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2000–2023

19

Publications

19

Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes

Tesfaye Biftu, Ranabir SinhaRoy, Ping Chen et al. · Journal of Medicinal Chemistry · 2014 · 167 citations · Full text

, , +16

Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents

Tesfaye Biftu, Dennis Feng, Michael H. Fisher et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 97 citations · Full text

, , +9

Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin

Tesfaye Biftu, Giovanna Scapin, Suresh B. Singh et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 69 citations · Full text

, , +17

Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents

Tesfaye Biftu, Dennis Feng, Mitree M. Ponpipom et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 53 citations · Full text

, , +12

Synthesis and biological activity of imidazopyridine anticoccidial agents: Part I

Andrew Scribner, Richard Dennis, Jean S. Hong et al. · European Journal of Medicinal Chemistry · 2007 · 52 citations · Full text

, , +12

1–5 of 19